Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Neurology, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Korean J Radiol. 2023 Feb;24(2):145-154. doi: 10.3348/kjr.2022.0618.
We aimed to evaluate the efficacy of EmboTrap II in terms of first-pass recanalization and to determine whether it could yield favorable outcomes.
In this multicenter, prospective study, we consecutively enrolled patients who underwent mechanical thrombectomy using EmboTrap II as a front-line device. The primary outcome was the first pass effect (FPE) rate defined by modified Thrombolysis In Cerebral Infarction (mTICI) grade 2c or 3 by the first pass of EmboTrap II. In addition, modified FPE (mFPE; mTICI grade 2b-3 by the first pass of EmboTrap II), successful recanalization (final mTICI grade 2b-3), and clinical outcomes were assessed. We also analyzed the effect of FPE on a modified Rankin Scale (mRS) score of 0-2 at 3 months.
Two hundred-ten patients (mean age ± standard deviation, 73.3 ± 11.4 years; male, 55.7%) were included. Ninety-nine patients (47.1%) had FPE, and mFPE was achieved in 150 (71.4%) patients. Successful recanalization was achieved in 191 (91.0%) patients. Among them, 164 (85.9%) patients underwent successful recanalization by exclusively using EmboTrap II. The time from groin puncture to FPE was 25.0 minutes (interquartile range, 17.0-35.0 minutes). Procedure-related complications were observed in seven (3.3%) patients. Symptomatic intracranial hemorrhage developed in 14 (6.7%) patients. One hundred twenty-three (58.9% of 209 completely followed) patients had an mRS score of 0-2. Sixteen (7.7% of 209) patients died during the follow-up period. Patients who had successful recanalization with FPE were four times more likely to have an mRS score of 0-2 than those who had successful recanalization without FPE (adjusted odds ratio, 4.13; 95% confidence interval, 1.59-10.8; = 0.004).
Mechanical thrombectomy using the front-line EmboTrap II is effective and safe. In particular, FPE rates were high. Achieving FPE was important for an mRS score of 0-2, even in patients with successful recanalization.
我们旨在评估 EmboTrap II 在首次再通方面的疗效,并确定其是否能带来有利的结果。
在这项多中心前瞻性研究中,我们连续纳入了使用 EmboTrap II 作为一线设备进行机械血栓切除术的患者。主要结局是 EmboTrap II 首次通过时改良后的血栓溶解治疗脑梗死(mTICI)分级 2c 或 3 的首次通过效果(FPE)率。此外,评估了改良后的 FPE(EmboTrap II 首次通过时 mTICI 分级 2b-3)、成功再通(最终 mTICI 分级 2b-3)和临床结局。我们还分析了 FPE 对 3 个月时改良 Rankin 量表(mRS)评分 0-2 的影响。
共纳入 210 例患者(平均年龄±标准差,73.3±11.4 岁;男性 55.7%)。99 例(47.1%)患者出现 FPE,150 例(71.4%)患者实现了改良后的 FPE。191 例(91.0%)患者成功再通。其中,164 例(85.9%)患者仅使用 EmboTrap II 成功再通。从股动脉穿刺到 FPE 的时间为 25.0 分钟(四分位间距,17.0-35.0 分钟)。7 例(3.3%)患者出现与操作相关的并发症。14 例(6.7%)患者出现症状性颅内出血。123 例(209 例完全随访患者的 58.9%)患者的 mRS 评分 0-2。16 例(209 例患者的 7.7%)患者在随访期间死亡。与未实现 FPE 的再通患者相比,实现 FPE 的再通患者 mRS 评分 0-2 的可能性高 4 倍(调整后的优势比,4.13;95%置信区间,1.59-10.8;P=0.004)。
一线使用 EmboTrap II 的机械血栓切除术是有效且安全的。特别是,FPE 率很高。实现 FPE 对于 mRS 评分 0-2 很重要,即使对于成功再通的患者也是如此。